FCER2
Basic information
Region (hg38): 19:7688758-7702146
Previous symbols: [ "CD23A", "FCE2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FCER2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 20 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 20 | 5 | 0 |
Variants in FCER2
This is a list of pathogenic ClinVar variants found in the FCER2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-7689204-GA-G | Likely benign (Dec 31, 2019) | |||
19-7689222-G-A | not specified | Uncertain significance (May 01, 2024) | ||
19-7689243-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
19-7689267-C-T | not specified | Uncertain significance (Jun 13, 2024) | ||
19-7689335-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
19-7689347-G-T | not specified | Uncertain significance (Apr 04, 2023) | ||
19-7689359-C-G | not specified | Uncertain significance (Jun 05, 2023) | ||
19-7689371-C-T | not specified | Likely benign (Apr 07, 2023) | ||
19-7689423-C-A | not specified | Uncertain significance (Feb 28, 2024) | ||
19-7690231-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
19-7690235-C-T | not specified | Uncertain significance (Jun 05, 2024) | ||
19-7690243-C-G | not specified | Uncertain significance (Mar 25, 2024) | ||
19-7690411-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
19-7690441-C-T | not specified | Uncertain significance (Aug 09, 2021) | ||
19-7690507-A-T | not specified | Uncertain significance (Aug 12, 2021) | ||
19-7696836-T-G | not specified | Uncertain significance (Jan 05, 2022) | ||
19-7696870-G-A | not specified | Uncertain significance (Jun 04, 2024) | ||
19-7697049-C-T | not specified | Likely benign (Aug 17, 2021) | ||
19-7697247-A-G | not specified | Uncertain significance (Apr 12, 2023) | ||
19-7697278-G-C | not specified | Uncertain significance (May 13, 2024) | ||
19-7697290-T-C | not specified | Uncertain significance (Dec 20, 2021) | ||
19-7697552-A-C | Likely benign (Jun 01, 2023) | |||
19-7697572-T-C | not specified | Likely benign (Nov 06, 2023) | ||
19-7698400-G-A | not specified | Uncertain significance (Jul 15, 2021) | ||
19-7698767-C-T | not specified | Uncertain significance (Oct 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FCER2 | protein_coding | protein_coding | ENST00000346664 | 10 | 13389 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
7.61e-12 | 0.0718 | 125615 | 1 | 132 | 125748 | 0.000529 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.592 | 221 | 198 | 1.12 | 0.0000117 | 2074 |
Missense in Polyphen | 58 | 45.112 | 1.2857 | 517 | ||
Synonymous | -0.669 | 90 | 82.3 | 1.09 | 0.00000550 | 607 |
Loss of Function | 0.317 | 18 | 19.5 | 0.923 | 9.52e-7 | 204 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000731 | 0.000730 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00461 | 0.00452 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000257 | 0.000255 |
Middle Eastern | 0.00461 | 0.00452 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Low-affinity receptor for immunoglobulin E (IgE) and CR2/CD21. Has essential roles in the regulation of IgE production and in the differentiation of B-cells (it is a B-cell-specific antigen).;
- Pathway
- Hematopoietic cell lineage - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);Signaling by NOTCH2;Human Complement System;Interleukin-10 signaling;Interleukin-4 and 13 signaling;Signal Transduction;il 4 signaling pathway;NOTCH2 intracellular domain regulates transcription;Signaling by NOTCH2;Signaling by NOTCH;IL4-mediated signaling events
(Consensus)
Intolerance Scores
- loftool
- 0.935
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.66
Haploinsufficiency Scores
- pHI
- 0.0703
- hipred
- N
- hipred_score
- 0.341
- ghis
- 0.523
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.700
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fcer2a
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- positive regulation of humoral immune response mediated by circulating immunoglobulin;Notch signaling pathway;cytokine-mediated signaling pathway;positive regulation of nitric-oxide synthase activity;positive regulation of killing of cells of other organism;positive regulation of nitric-oxide synthase biosynthetic process
- Cellular component
- plasma membrane;integral component of plasma membrane;external side of plasma membrane;extracellular exosome
- Molecular function
- integrin binding;protein binding;IgE binding;carbohydrate binding;metal ion binding